@platinumstandard, thanks for explaining. I had missed the link to the full publication which comprehensively answered these questions.
https://api.eurointervention.com/v1/articles/17355/download/pdf
My last sentence wasn’t meant to be funny… I was recalling that some procedures were done surgically but may have been thinking back to the animal trials. For the FIH study it appears that the first 5 patients were tested with a modified procedure: “The first cohort of five (5) patients enrolled in November The first cohort of five (5) patients enrolled in November 2021 underwent TAVI procedure with direct aortic approach. 2021 underwent TAVI procedure with direct aortic approach.”
There is some more detail about the other complications, too: “Several challenging anatomies were treated in this FIH study, including patients with severe annular calcium, extreme leaflet calcium, type 1 bicuspid, and severe left ventricular outflow tract (LVOT) calcium”
As you say, the sort of things that go with the territory.
cheers,
exee
- Forums
- ASX - By Stock
- AVR
- Ann: FIH Results Presented at EuroPCR & Simultaneous Publication
Ann: FIH Results Presented at EuroPCR & Simultaneous Publication, page-22
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.00 |
Change
-0.350(2.02%) |
Mkt cap ! $327.3M |
Open | High | Low | Value | Volume |
$17.00 | $17.44 | $16.95 | $150.7K | 8.86K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1552 | $17.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.13 | 8 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1552 | 17.000 |
1 | 27 | 16.970 |
1 | 27 | 16.960 |
2 | 584 | 16.950 |
1 | 682 | 16.910 |
Price($) | Vol. | No. |
---|---|---|
17.130 | 8 | 1 |
17.170 | 16 | 1 |
17.190 | 39 | 2 |
17.280 | 130 | 1 |
17.500 | 500 | 1 |
Last trade - 11.26am 19/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |